共 137 条
[1]
Legius E(2021)Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation Genet Med 23 1506-1513
[2]
Messiaen L(2005)The nature and frequency of cognitive deficits in children with neurofibromatosis type 1 Neurology 65 1037-1044
[3]
Wolkenstein P(1999)Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation Am J Pathol 155 1879-1884
[4]
Pancza P(2019)Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment Pain 160 1007-1018
[5]
Avery RA(2015)Skeletal muscle and motor deficits in neurofibromatosis type 1 J Musculoskelet Neuronal Interact 15 161-170
[6]
Berman Y(2016)Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography Clin Ophthalmol 10 851-860
[7]
Hyman SL(2014)Plexiform neurofibroma treated with pharmacopuncture J Pharmacopunct 17 74-86
[8]
Shores A(2015)Neurofibromatosis type 1 Handb Clin Neurol 132 75-196
[9]
North KN(2019)Patient reported outcomes measurement information system and quality of life in neurological disorders measurement system to evaluate quality of life for children and adolescents with neurofibromatosis type 1 associated plexiform neurofibroma J Pediatr 206 190-495
[10]
Nielsen GP(2012)Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression Annu Rev Pathol 7 469-311